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Abstract
Several studies have been conducted that link poor control of hemoglobin A1c (HbA1c)
to an increased risk of heart disease. However, there are limited published studies that
link HbA1c and heart disease based on ethnicity and gender. To address this gap in
literature, the purpose of this study was to assess the association between HbA1c and
heart disease in African American males (aged 30–64 years old) while controlling for
education, income, and access to care. The research questions were focused on
establishing an association between HbA1c values and heart disease in African American
men through the lens of the health belief model. Secondary data (N=243) were used from
the Nutritional Health and Examination Survey (2011-2016) and analyzed. . Chi-square
analysis and multiple logistic regression were conducted to test for an association
between HbA1c and heart disease in men aged 30–64 years old. The variables of Hba1c
values, various forms of heart disease, and stroke were tested while controlling for age,
education, income, and access to care. Key results indicated no association between
HbA1c and heart disease; yet, it is recommended that future research on the topic should
include a larger sample of those with heart disease, from other sources, to better assess
the outcome. The positive social change implications include the addition of research
related to gender-specific outcomes and ethnicity-related risk between HbA1c and heart
disease, which can be used to achieve better disease management and provide educational
opportunities for diabetic African-American men.
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Chapter 1: Introduction to the Study

Introduction
In this quantitative study, I examined which factors increase the diagnosis of heart
disease in African American males aged 30–64 years old. There is ample knowledge that
diabetes can lead to heart disease; however, there is no published information on this
association by ethnicity and gender. According to the American Heart Association
(American Heart Association [AHA], 2017a), heart disease is the leading cause of death
in the United States. African Americans are more likely to die from heart disease due to
social and environmental risk factors such as stress, diet, and exercise, which present
challenges for healthy lifestyles and disease prevention (AHA, 2017a). The overall
significance of this study lies in the results which will allow diabetics the opportunity to
make lifestyle changes and be proactive in their own health prior to the development of
cardiac disease. The positive social change implications of this study include the
addition of research related to gender-specific outcomes and ethnicity-related risks
between hemoglobin A1c (HbA1c) and heart disease, which can be used to achieve
better disease management and provide educational opportunities for diabetic AfricanAmerican men. Chapter 1 will include the following sections: background of the
research problem, the problem statement to address the lack of research by ethnicity and
gender, the purpose of the study, research questions and hypotheses, theoretical
foundation, the nature of the study, definitions, assumptions, scopes and delimitations,
limitations and significance.
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Background
Diabetes is a chronic condition that affects multiple organs and organ systems
within the body, including the cardiovascular system (Mayo Clinic, 2018c).
Characterized by a chronically high glucose level in the blood, diabetes causes plaque to
build up in the heart, leading to an increase in cholesterol (Mayo Clinic, 2018c). This
plaque buildup causes a reduction in blood flow, which can lead to high blood pressure,
heart attacks, stroke, and even death (Boehringer Ingelheim Pharmaceuticals, 2016).
According to Traylor et al. (2010), patient ethnicity is associated with risk factors and
treatment options in both diabetes and heart disease. However, further research is needed
to identify potential disparities in HbA1c values and the development of heart disease
(Jeppesen, Hein, Suadicani, & Gyntelberg, 1998; Traylor et al., 2010).
It is unknown whether early intervention, from the time of a diabetes diagnosis,
can prevent heart disease. Although researchers agree that diabetes is a risk factor for
heart disease, enough data does not exist to support recommendations to change current
practice in the treatment of diabetes to help prevent the development of heart disease by
ethnicity (Rana, Liu, Moffet, Jaffe, & Karter, 2016). Both the AHA and the American
Diabetes Association (ADA) agree that lifestyle and medical interventions can delay or
reduce the development of heart disease, allowing diabetics to live longer, healthier lives
(Buse et al., 2007). One of the main questions being asked by the research community
and medical providers is why African Americans are not receiving recommended
treatments (Vulic, Lee, Dede, Lopez, & Wong, 2010). Barriers to treatment options lead
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to suboptimal control of heart disease risk factors and HbA1c target goals (Malik, Lopez,
Chen, Wu, & Wong, 2007).
There are few extant research studies that have used prediction models to assess
various forms of heart disease and diabetes to prevent death and improve quality of life
(McEwen et al., 2012). In this study, I focused solely on coronary heart disease (CHD),
hypertension (HTN), high cholesterol, heart attack, and stroke and how these forms of
heart disease are associated with HbA1c levels in African American men while
controlling for age, education, income, and access to care. Whiteley, Padmanabhan, Hole,
and Isles (2005) suggested that diabetes risk factors be treated as aggressively as heart
disease risk factors. This is further supported by the Framingham Risk Score, which
predicts heart disease and has shown multiple risk factors between diabetes and
cardiovascular disease (CVD; Whiteley et al., 2005). When adding in HbA1c to the risk
factors identified by the Framingham Risk Score, a statistically significant improvement
was seen in men that predicted an increase in risk for development of heart disease
(Simmons et al., 2008). When diabetes was identified as a risk factor within the first 10
years of diagnosis, a significant improvement was seen in all-cause mortality in men
(Wannamethee, Shaper, Whincup, Lennon, & Sattar, 2011).
In 2005, researchers started asking whether diabetes should be considered a risk
factor for CHD (Muntner et al., 2005; Selvin et al., 2005; Whiteley et al., 2005). In 2010,
researchers examined the Nutritional Health and Examination Survey (NHANES) from
2005–2006 and concluded that efforts were still needed to implement guidelines to
adequately treat heart disease risk factors including diabetes (Vulic et al., 2010). Further
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research in 2010 corroborated these findings and added that in the ADA’s view, evidence
exists to support an association with higher HbA1c levels and heart disease (Matsushita
et al., 2010; Selvin et al., 2010). By 2015, researchers were publishing data to support the
use of drug therapy to eliminate heart disease risk factors found in Type 2 diabetics
(Strang et al., 2015). This was an important milestone in research because those with
diabetes were not meeting risk factor controls to prevent the development of heart disease
(Mark et al., 2015). By 2015, the AHA and the ADA published an update on the most
recent evidence to support the need for new diabetic guidelines to manage diabetes and
prevent adverse outcomes related to poor glycemic control (Fox et al., 2015). These
outcomes included blood pressure management, cholesterol management, and glucose
control (Fox et al., 2015).
Although there is some ethnicity-based research on the relationship between
diabetes and genetics, there is limited published data on diabetes and heart disease by
ethnicity. India, known as the diabetes capital of the world, has established a phenotype
that shows high insulin resistance in individuals with Type 2 diabetes (T2DM; Raj,
Bhatti, Badada, & Ramteke, 2015). This phenotype in T2DM leads to low insulin
sensitivity, insulin resistance, and higher levels of coronary artery disease (Babikr,
Alshahrani, Hamid, Abdelraheem, & Shalayel, 2016). Longitudinal studies in adults have
shown that early diabetic interventions do reduce cardiovascular complications and
mortality (Babikr et al., 2016). In addition, in a study of an indigenous Australian
community, researchers identified individuals at substantial risk for developing diabetes
and showed those with and without diabetes may already have early onset heart disease
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based on HbA1c values (Arnold, Hoy, Sharma, & Wang, 2016). The results of my study
might provide early identification of at-risk diabetic individuals and might produce
evidence that could be used to decrease the chance of serious heart disease in the African
American male population.
Problem Statement
The problem I addressed in this study was the lack of research on the association
between HbA1c and heart disease in the male African American population while
controlling for age, education, income, and access to care. Disparities in HbA1c have
been shown between African Americans, Asian Americans, and Latinos (Kirk et al.,
2006). Researchers have also suggested that HbA1c control may be poorer among
African American populations when compared to Whites, related to lack of preventive
care (Kirk et al., 2006). The results of this study add to the extant literature with
assessments of HbA1c levels and the risk of developing heart disease based off HbA1c
levels in the male African American population, a topic area that has not been covered in
previous research.
Heart disease accounts for 31% of deaths worldwide (Cavero-Redondo, Peleteiro,
Alvarez-Bueno, Rodriguez-Artalejo & Martinez-Vizcaino, 2017; World Health
Organization [WHO], 2017) and is the leading cause of mortality in Type 2 diabetics
(Banovic et al., 2016). Diabetes is known to cause plaque to build up in the heart, which
allows cholesterol to increase (AHA, 2017a). This build-up can then cause a reduction in
blood flow leading to CHD, high blood pressure, heart attacks, stroke, and even death
(AHA, 2017a; National Institute of Diabetes and Digestive and Kidney Diseases
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[NIDDK], 2017a). According to Arnold et al. (2016), individuals with diabetes have
higher rates of vascular disease than nondiabetics. Therefore, understanding the
characteristics of a diabetes diagnosis is essential to establishing therapeutic goals to
prevent CVD. With this study, I aimed to determine whether there is an association
between HbA1c and heart disease in the male African American population aged 30–64
years old. I chose the age of 30 years old to eliminate the chance of including only Type
1 or juvenile diabetics, and I chose the age 64 years old because there is a greater chance
of preexisting cardiovascular complications by this age.
Purpose of the Study
The purpose of this quantitative study was to assess for an association between
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in
known diabetic African American men aged 30–64 years old. Covariates included:
education, income, and access to care. My intent with this study was to explore the
association between heart disease and HbA1c in African American men with diabetes. I
wanted to also test for an association between HbA1c values and heart disease while
controlling for education, income, and access to care. This research was limited in nature
to diabetic African American men age 30-64.

Research Questions and Hypotheses
The study was limited to African American men diagnosed with diabetes and
aged 30–64 years old. I used a research strategy incorporating chi-square analysis, and
multiple logistic regression to test the following research questions:
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Research Question 1: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old?
H01: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.
Ha1: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.
Research Question 2: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30-64 years old after
controlling for education, income, and access to care?
H02: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care.
Ha2: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care.

Theoretical Framework
In this study, I used the health belief model (HBM) as the theoretical framework
to describe the association between HbA1c and cardiac disease outcomes. The HBM is a
theory based on health behavior and focuses on four principal areas: the severity of the
illness, how susceptible a person is to an illness, the benefits of preventative care, and
actual or potential barriers that keep an individual from acting to prevent disease
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progression (Current, 2012). This model can also be used to help individuals with the
perception of their beliefs in relation to their behaviors (Current, 2012).
In this study, I used the HBM to address health concerns, such as how HbA1c
contributes to heart disease in the African American male population. By understanding
the relationship between diabetic control and the impact unmanaged diabetes has on heart
disease, the quality of life in this population can be improved. The HBM can be used to
design both short and long-term interventions based on the study results. In new on-set
diabetes, short and long-term interventions can include medication management, and in
known diabetics, this can include preventative care to delay further development of heart
disease. In this study, I gathered the necessary information to perform a needs assessment
of the population at risk. The interpretation of these results will convey when individuals
are at an increased risk for heart disease based on HbA1c levels, age, education, income,
and access to care (Rural Health Information Hub, 2018). When used appropriately, the
HBM will provide an organized assessment of the risks related to increased HbA1c and
heart disease outcomes (Tarkang & Zotor, 2015).
By identifying those most at risk and understanding the relationship between
HbA1c and the development of heart disease, a tool is created that encompasses a
detailed plan to adopt health promotion and disease prevention programs. In the African
American male population, barriers to care include lack of knowledge of the disease
process, lack of time, and lack of support (Crabtree et al., 2015). In the Crabtree et al.
(2015) study, men expressed a desire for diabetic interventions to improve selfmanagement skills and diabetes-related health outcomes. Additionally, free, convenient,

9
culturally sensitive and gender appropriate programs were requested (Hurt, Seawell, &
O’Conner, 2015). Social change will stem from adding to the current research on this
topic by identifying ethnic risks related to HbA1c and heart disease as well as creating a
plan of action to improve the self-management skills and diabetic-related health
outcomes in this population, leading to better disease management and educational
opportunities.
Nature of the Study
The nature of this study was a quantitative design based on an analysis of
secondary data. The independent variable was HBA1c, and the dependent variable was
heart disease. With the results of this study, I aimed to identify those at high risk of heart
disease based on HbA1c values, using a multiple logistic regression model. Sample data
were grouped into age categories, which were used to define the sampling framework.
HbA1c levels were obtained from NHANES and analyzed based on recommended
guidelines from the Mayo Clinic. I collected the data from the NHANES 2011–2016 after
receiving Walden University Institutional Review Board (IRB) approval.
Definitions of Terms
Access to care: Having a usual source of care (Spatz, Ross, Desai, Canavan, &
Krumholz, 2010) through health insurance. This can be via private insurance, Medicare,
Medicaid, Military health care, state-sponsored health plan, other government insurance,
or a single service plan (Centers for Disease Control and Prevention [CDC], 2015b).
Cardiovascular disease (CVD): Also known as heart disease, CVD is a condition
in which blood vessels narrow and block vessels in the heart (Mayo Clinic, 2018b). This

10
can then lead to heart attacks, chest pain, or stroke (Mayo Clinic, 2018b). In addition,
CVD is grouped into disorders to include peripheral artery disease, peripheral vascular
disease, diseases of the heart and heart muscle, HTN, stroke, heart failure, and coronary
heart disease (WHO, n.d.). For this study, CVD was defined as having a history of HTN,
heart attack, or stroke.
Coronary heart disease (CHD): Also known as coronary artery disease, CHD is
the formation of plaque, or a fatty substance, that builds up on the walls of coronary
arteries leading to atherosclerosis or the hardening of the artery walls (National Heart,
Lung, and Blood Institute, n.d.). If a piece of this plaque breaks off a clot can occur
(AHA, 2017a). Another consequence of CHD is heart attack or stroke (AHA, 2017a;
National Heart, Lung, and Blood Institute, n.d.).
Diabetes: A disease that occurs that keeps your blood glucose (i.e., blood sugar)
to high, having too much blood glucose can lead to chronic health conditions (NIDDK,
2016). These health conditions can cause heart disease, blindness, renal disease, and
peripheral vascular disease leading to the loss of limbs (CDC, n.d.).
Glycated hemoglobin (HbA1c): The level of sugar in your body over a 2- to 3month time (ADA, 2014) and helps to determine the amount of hemoglobin that is
covered with sugar (Mayo Clinic. 2018a). This is an important number used to manage
diabetes (Diabetes CO UK, 2018). The higher this number, the greater the risk becomes
of developing diabetic complications (Diabetes CO UK, 2018). The recommended
HbA1c level is different by organization, and the patient’s physician will determine what
is appropriate for an individual based on other health conditions. Currently, the ADA
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recommends an HbA1c of 7% or less (ADA, 2014). Those between 5.7%–6.4% are
prediabetic, and those with HbA1c over 6% should be considered high risk for
developing diabetes (ADA, 2018). Adults with diabetes are more likely to develop heart
disease and die from a heart attack or stroke at a younger age than those without the
disease (NIDDK, 2017).
Hypertension (HTN): A disease where the force of blood going through your
blood vessels is consistently too high; more than half of adults have high blood pressure
(AHA, 2017b). For many, there are no symptoms, but if not treated an individual can
suffer a heart attack, stroke, or other health complications (AHA, 2017a). Normal blood
pressure is less than 120/80, elevated is systolic between 120–129 and diastolic less than
80, Stage 1 is systolic 130–139 or diastolic 80–89, Stage 2 is systolic of 140 or higher or
diastolic of 90 or higher (American College of Cardiology Foundation, 2018).
Type 2 Diabetes (T2D): A disease where your body is unable to make or use
insulin; this type of diabetes is often seen in middle-aged and older individuals (NIDDK,
2016). This type of diabetes is also called insulin resistant diabetes and is the most
common form of diabetes (NIDDK, 2016). This type of diabetes keeps your blood sugars
out of the normal range (ADA, n.d.b.). Your body either resists or does not make enough
insulin to regulate the amount of sugar found in your bloodstream (Mayo Clinic, 2018c).

Assumptions
I made several assumptions in this study. One of them was that the NHANES
database adequately represents the African American male population in its entirety.
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Another assumption was that HbA1c levels were reported correctly and that there were
no lab errors in the processing of the specimens. I also assumed that those reporting heart
disease understood the working definition of the term and the subsequent cardiac diseases
that were under the umbrella of that definition. Finally, it was assumed that the secondary
data used were accurately collected and reported.

Scope and Delimitations
In this study, I evaluated the association between HbA1c and reported
cardiovascular events in African American men. This study was conducted using data
from NHANES 2011–2016. By evaluating multiple years, the sample size is more likely
to be representative of the population being studied. I focused on men aged 30 to 64 years
of age. The focus on men over age 30 was to eliminate most Type 1 diabetics, and those
over age 64 was to eliminate men that may have suffered from more serious cardiac
events. The African American community is at high risk for diabetes and subsequent
cardiovascular events (George, Selvin, Pankow, Windham, & Folsom, 2017; Selvin et al.,
2016). I used the HBM as the theoretical framework.
Limitations
I identified several limitations in this study. One of the limitations related to the
amount of data that were available. Additional limitations centered on the lack of
available data that focused solely on African American men versus all men or all African
Americans as a whole. Available data were grouped into categories that did not separate
out ethnicity or disease burden by disease type. To clarify, there have been cardiovascular
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studies that focused on men but not just on African American men or a single ethnicity.
The same is held true when researching diabetic outcomes in African American
populations. The extant research has often focused on the entire ethnic population and not
separated by gender. Thus, the data does not truly capture the association of disease by
ethnicity and gender. Finally, a limitation was placed on knowing whether the participant
was a Type 1 or Type 2 diabetic because HbA1c values do not clearly define the type of
diabetic an individual is.
Significance of the Study
The results of this study can be used to identify those at substantial risk for heart
disease and were aimed at identifying heart disease risk based on HbA1c values. I
conducted this quantitative analysis to determine whether there is an association between
HbA1c values and heart disease and adjusted for age to assess which group is most at risk
for heart disease based on HbA1c values. By including HbA1c values into routine
physical exams, elevated HbA1c levels can be monitored for the development of heart
disease. These rising values not only address the potential risk of developing diabetes but
also the potential risk for developing heart disease. With less than half of all adults in the
United States meeting guidelines for diabetic care, the ADA and AHA have jointly
established new recommended guidelines for the prevention and treatment of diabetes to
reduce microvascular complications, which lead to adverse heart disease (Fox et al.,
2015). These recommendations include risk factor management and screening for CVD
complications in all populations (Fox et al., 2015). The results of this study provide the
data needed to support the findings of the ADA and AHA in terms of glucose
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management and prevention of CVD outcomes. Social change implications include the
addition of research related to gender-specific outcomes and ethnicity-related risk
between HbA1c and heart disease, leading to better disease management and educational
opportunities. The findings of this study provide evidence that HbA1c levels may predict
heart disease and allow for early intervention by healthcare providers, which could come
through lifestyle changes or medication management.

Summary and Conclusion
In this chapter, I reviewed the need for further research on the association
between HbA1c and heart disease in diabetic African American men. Several studies
have been conducted to link poor HbA1c control to heart disease; yet, there are few, if
any, published research articles that link HbA1c values and heart disease by ethnicity. In
this chapter, I previewed the background on diabetes and how diabetes affects the
cardiovascular system. The main problem statement was addressed and described my
focus on the disparities in relation to diabetes risk factors and heart disease outcomes in
this study. The purpose of this quantitative study was to determine the association
between HbA1c and heart disease in the African American population. Research
questions were provided along with the corresponding null and alternative hypotheses. In
addition, I identified the theoretical framework as the HBM, the definitions and
assumptions, and the study limitations. This chapter concluded with the significance of
the study and the implications for positive social change. In Chapter 2, I will address gaps

15
in the literature about the association between HbA1c, heart disease, and diabetic African
American males.
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Chapter 2: Literature Review
Introduction
Diabetes is a chronic medical condition that affects 4.9 million African Americans
(ADA, n.d.a). Additionally, the African-American population is 1.7 times more likely to
develop diabetes than their White counterparts (U.S. Department of Health and Human
Services Office of Minority Health [DHHS], 2016). Since 1994, the percentage of
African Americans with diabetes has steadily increased from 9.1% to 13.4% in 2014
(DHHS, 2016). Diabetes is a known precursor to heart disease and is strongly associated
with the development of heart disease (Xanthakis et al., 2015). Research has also shown
that heart disease can develop from diabetic complications and is ranked as a top cause of
mortality in American people (AHA, 2017a) with African Americans consistently
ranking as the highest risk compared to other ethnicities (Lee et al., 2013). With this
study, I aimed to identify an association between heart disease risk based on age and
HbA1c levels in African American men.
According to current publications, there is a lack of research on the association
between diabetes and CVD by race and gender, and there are no published studies that
address gender and CVD in African American men (George et al., 2017; Regensteiner et
al., 2015; Xanthakis et al., 2015). Further research is needed to understand the
relationship between high blood sugars (i.e., HbA1c) and heart disease to establish
whether there is a need for intervention using medication therapy (George et al., 2017).
Additionally, the current research has only estimated a greater relative risk for CVD
development among White woman with diabetes, creating the potential for research bias
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by ignoring competing risk factors (George et al., 2017; Xanthakis et al., 2015). These
risks may prove to be modifiable if the standard of practice for diabetic patients changes
to encompass pretreatment of heart disease.
In this chapter, I cover historical and current literature on the association between
HbA1c and CVD; the strategy used to conduct the literature review; and go into more
detail about the HBM, being used as the theoretical framework. Key concepts and the
pathophysiology of diabetes and heart disease are explored. The chapter concludes with
an explanation of why the study should be conducted. The results of this study provide
information that can be used to establish clinical guidelines to assist in identifying risk
factors that lead to major heart disease in diabetics and help to decrease the number of
years lost related to disease manifestation.
Early intervention, from the time of a diabetes diagnosis, may prevent heart
disease (Tuso, 2014). In this study, I focused on the lack of research that has been
conducted on the association between heart disease and HbA1c levels in the nonHispanic Black male community (see Gray et al., 2016; Jeppesen et al., 1998; Traylor et
al., 2010), and while it is agreed upon that diabetes is a risk factor for heart disease, there
are no published research studies that focus on African American men and how HbA1c is
associated with heart disease. These studies are needed to prevent death and improve the
quality of life of individual ethnicities to include Hispanic, African American, and
Asian/Pacific Islanders (McEwen et al., 2012).
According to Traylor et al. (2010), patient ethnicity is associated with diabetes
risk factors and treatment outcomes. These diabetic risk factors influence cardiac risk
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factors when associated with diabetic treatment options (Traylor et al., 2010). Both the
AHA and the ADA agree that lifestyle and medical interventions can delay or reduce the
development of heart disease, allowing diabetics to live longer, healthier lives (AHA,
2017a; Buse et al., 2007). When heart disease is treated as a risk factor in diabetes and
within the first 10 years of a diabetes diagnosis, a significant improvement was seen in
blood glucose levels (p < .001) and in HbA1c levels (p = .006; Wannamethee et al.,
2011). In the United Kingdom Prospective Diabetes Study (UKPDS), for every
percentage point reduction, heart disease risk decreased 24% (Kirk et al., 2006; Wenzel
& Unger, 2016). These risk factors fall in line with the ADA 2017 Standards of Care
which identified the need to promote health and reduce disparities in populations with
diabetes. Standard 9 of the ADA 2017 Standards of Care identifies the fact that control of
HbA1c has led to a reduction of heart disease in diabetic patients (ADA, 2017a). Overall,
there is sufficient data that supports a correlation between diabetes and heart disease
(Selvin et al., 2005; Traylor et al., 2010). However, there are not enough studies that
represent individual ethnic populations in relation to diabetes and heart disease.
According to Selvin et al. (2016), little data exists on HbA1c and heart disease outcomes
in Blacks. There is also little known about gender differences in African Americans, and
there are no studies that test the interaction of diabetes and heart disease outcomes in
African Americans (George et al., 2017). In this study, I focused on a gap in the literature
regarding data to support the relationship between HbA1c and heart disease in the male
African American population. As stated by Thorpe et al. (2017), targeting intervention
strategies and the identification of preventable or modifiable risk factors is consistent
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with health disparities research. For this reason, I focused solely on the male, African
American population adding to the research that focuses on the health and functional
status of this population.
Literature Search Strategy
I conducted the literature review using multiple databases, including EBSCOhost,
Science Direct, ProQuest, PubMed, Ovid, CINAHL, the CDC, Circulation, and Sage
Journals. Keywords used to locate published research were diabetes, Type 2 diabetes,
glycated hemoglobin A1c, HbA1c, hemoglobin A1c, cardiovascular disease, heart
disease, Black, African American, and non-Hispanic Black. The literature review
included sources published from 2005–2018. I used articles published before 2005 as
historical documents and reference articles for additional literature searches,
methodologies, or keywords.

Theoretical Foundation
In this study, I used the HBM as the theoretical framework to analyze the
relationship between HbA1c and heart disease. In this section, I will discuss the
theoretical propositions for this theory and how it has been previously applied to similar
studies. This section is organized into the following subsections: overview, previous
studies that used the HBM, and other theories that could have been used in this project.
Overview
The HBM was developed in the 1950s to understand why individuals did not
accept disease prevention or screening tests to detect asymptomatic disease (Ebomoyi,
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2013; Webster & Heeley, 2010). One of the constructs of this theory is perception, which
is influenced by personal factors to include education and parental influence (Ebomoyi,
2013). Two other components of this theory focus on an individual’s desire to avoid
illness and the belief that preventive care can stop illness from occurring (Webster &
Heeley, 2010). This component includes the self-management of diabetes and adhering to
diet and exercise regimes to control HbA1c values. This model has been used in previous
CVD studies to identify perceived susceptibility as the main factor for compliance. In
addition, by organizing a family history tree with chronic medical conditions, the threat
of a chronic health condition becomes visual for the individual (Ebomoyi, 2013). This
then leads to cues for action, because the perceived seriousness of disease has the greatest
impact on health belief (Cao, Chen, & Wang, 2014).
The results of this study provide key information on how the HBM can be used to
identify personal and familial risk for the development of heart disease in diabetic
individuals. The HBM can then be used to design both short and long-term interventions
based on the study results, which adds to the foundation of the HBM, in which perceived
susceptibility is validated by the data obtained. The use of HBM in this manner allows for
calculation of the perceived severity of disease complications, when compared to HbA1c
values and heart disease outcomes based on age, education, income, and access to care
(see Ma, 2018).
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Previous Studies
The HBM is not typically used as a primary model in the analysis of secondary
data. While theories, such as the grounded theory, Orem’s theory of self-care, the
explanatory theory, and the change theory, were also explored, I chose the HBM based
on previous research studies that utilized this theory. Most of the studies that employed
the HBM focused on the process of disease. In a review of studies, the strength of
association between the perception of disease risk and the factors related to risk severity
were explored (Brewer, Chapman, Gibbons, Gerrard, & McCail, 2007). These studies
showed a similar consistency, and strength of association, between the risk of disease and
behavior. This review also showed how applying the HBM to my research may improve
the ability to predict the severity of disease and identified perceived susceptibility. The
HBM will enable researchers to develop a method that shows how heart disease is
associated with HbA1c in diabetics.
When combining the term HBM and secondary data, I found additional
information in the literature to support the role of the HBM and diabetes and the HBM
and heart disease. A common similarity between the extant studies was a need for
culturally sensitive information related to the African American male population
(Crabtree et al., 2015; Hurt et al., 2015; Tarkang & Zotor, 2015). This was noted in
several research articles that explored compliance with disease management and the
relation of statistical data to outcome driven incentives.
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In this study, my use of HBM helped establish whether there was an association
between HbA1c and heart disease when accounting for age, education, income, and
access to care. This model allows for intervention measures and education to be provided
to this population to deter from the beliefs that men should be strong, avoid vulnerability,
and that “black men [are] diabetic” (Hurt et al., 2015, p. 5) By incorporating sensitivity
training and having other African American mentors as role models, the collected data
assists in changing the beliefs that diabetes is a disease that is expected. Instead, men
were taught that to maintain the role of provider and head of household, preventive
measures must be taken to decrease the chance of disease progression. Such information
needs to be given free of charge and at convenient times for this population and be
presented by someone who understands Black culture. This will ensure that the
individuals are spoken to appropriately and not spoken down to and allow for culturally
sensitive and gender appropriate interventions (Hurt et al., 2015). These interventions
will help displace myths about diabetes that include how diabetes is developed, what
foods cause diabetes, and the seriousness of diabetes (ADA, 2017b). Each of these topics
falls into the belief of how the disease progresses and is treated based on the results of
this data.
Literature Review Related to Key Concepts
Pathophysiology
Diabetes is a risk factor for CVD, with HbA1c also being a predictable risk factor
for cardiovascular mortality (Cavero-Redondo, et al., 2017; Ford & DeStefano, 1991).
Heart disease accounts for 31% of deaths worldwide (Cavero-Redondo, et al., 2017;
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WHO, 2017) and is the leading cause of mortality in T2DM (Banovic et al., 2016). The
evidence to support the dominant contributor to hyperglycemia in patients with HbA1c <
8.5%, focuses on postprandial levels, while fasting glucose levels are a major contributor
to higher HbA1c levels (Borg et al., 2010). Fasting glucose levels are the dominant
contributor to HbA1c levels in diabetics with glycohemoglobin levels > 8.5% (Borg et
al., 2010; Moher, Liberati, Tetziaff, & Altman, 2009). Additionally, higher levels of
glycohemoglobin were significantly associated with higher hazard ratios for
cardiovascular mortality (Cavero-Redondo et al., 2017). Thus, glycohemoglobin (i.e.,
HbA1c) has been shown to be a stronger predictor of heart disease than fasting glucose
(Cederberg et al., 2010). Several epidemiological studies have also shown an association
between 2-hour post-oral glucose tolerance tests and increased mortality and heart
disease (Borg et al., 2010). Yet, HbA1c correlated with average blood glucose levels is
the diagnostic standard introduced by the World Health Association in 2011 (Borg et al.,
2010; Gray et al., 2016).
Diabetic Complications
Glycated hemoglobin (HbA1c) is an indicator of the average blood glucose over a
2-3-month time frame and is the recommended method for a diagnosis of diabetes (ADA,
2017a; McNeely et al., 2009; WHO, 2011). These high blood glucose levels can damage
the heart and blood vessels (NIDDK, n.d.). However, HbA1c levels can be used to create
an algorithm for cardiovascular risk using age, gender, smoking status, blood pressure,
and cholesterol levels and determining variables (Cavero-Redondo et al., 2017). Yet,
there are no large studies examining HbA1c and cardiac disease in ethnic minority
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populations to support this (Kirk et al., 2006; McNeely et al., 2009; Thorpe Jr.. et al.,
2017).
Prior studies revealed how diabetic complications affect the African American
population. These diabetic complications are experienced at a higher rate in African
Americans leading to a 46% higher chance of developing renal disease and kidney failure
resulting in dialysis than non-Hispanic Whites (Kirk et al., 2006). Additionally, older
African Americans consistently have a higher prevalence of chronic conditions than older
White adults with diabetes, heart disease, and stroke being the highest cause of disability
in African American men (Thorpe Jr. et al., 2017). Disparities in HbA1c have been
shown between African Americans, Asians, and Latinos and literature has suggested that
HbA1c control may be poorer among minority populations, with access to quality care
suggesting less optimal diabetic care and subsequent diseases, related to lack of
preventive care (Kirk et al., 2006). Additionally, there has not been a study that focuses
on HbA1c and diabetics in African American populations (Kirk et al., 2006; McNeely et
al., 2009; Thorpe Jr. et al., 2017). Kirk et al. (2006) conducted the first meta-analysis
showing that African Americans have a higher elevated HbA1c compared to nonHispanic whites with an effect size difference of ~0.65% (Kirk et al., p. 4, 2006). Kirk et
al. then concludes that further research is needed to understand why African Americans
have poorer glycemic control than non-Hispanic Whites, and to further identify
interventions that can be made to prevent cardiovascular disease. Concluding that there is
little research on the association between diabetes and disabilities related to diabetes in
African Americans (Thorpe Jr. et al., 2017).
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Heart Disease
The optimal range for low mortality between HbA1c and heart disease is an
HbA1c range from 6-8% (Cavero-Redondo et al., 2017). Low mortality, as defined by the
number of life-years lost, is an HbA1c in this range, factoring in length of disease,
treatment of disease, and adherence to treatment (The Emerging Risk Factor
Collaboration, 2011). This then shows that the number of life-years lost can be decreased
from 3-4 years by age 65, 2-2.5 years by age 75, and 1-1.5 years by 85 (The Emerging
Risk Factor Collaboration, 2011). There is also an increase in mortality seen in diabetics
with HbA1c ≥ 7.5% (Cavero-Redondo et al., 2017), and for every 1% increase in HbA1c,
the risk for cardiovascular mortality goes up by 5% (Cavero-Redondo et al., 2017).
T2DM has also been shown to contribute to poor outcomes in patients that develop heart
disease (Banovic et al., 2016). Leading to the conclusion that HbA1c is a risk factor for
heart disease and cardiovascular mortality in diabetic patients.
In African Americans, woman have a greater risk of heart disease than male
African Americans. Additionally, African American men are 30% more likely to develop
heart disease than White males (Graham & Garcia, 2012). In 2015, ADA and AHA
guidelines jointly agreed that practice guidelines be changed. These changes reflect best
practice guidelines for diabetics and recommend statin therapy in individuals over the age
of 40 that do not have severe heart disease. Diabetics between 40 and 75 years with
cholesterol levels ranging from 70-189 mg/dL should also be on medication to control
CVD (Fox et al., 2015).
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African Americans are two times more likely to be diagnosed with diabetes than
non-Hispanic Whites (DHHS, 2016). The rate of diabetes has been shown to be 2-3 times
higher in the African American population than in whites (Mouton, Hayden, &
Southerland, 2017; Wenzel & Unger, 2016). In 2009, heart disease killed 46,334 African
American men, with nearly half of African American adult males, 46%, having some
form of heart disease (Mouton et al., 2017, p. e38). This group also has a shorter life
expectancy than their White male counterparts, 74.3 years for White men; 67.2 years for
African American men (Mouton, et al., 2017, p. e38). Making heart disease a major
contributor to health disparities in African American mortality (Mouton et al., 2017).
While there are several risk factors to heart disease in this population, the focus remains
on the association between HbA1c and heart disease.
In the African American population, 13.5% of men over the age of 20 years old,
have diabetes that has been diagnosed by a physician (Mouton et al., 2017). Diabetes then
leads to vascular complication which leads to a higher mortality rate in African American
men than in non-Hispanic Whites (Mouton et al., 2017). According to the UKPDS and
the Diabetes Control and Complications (DCCT) trial, a 1% decrease in diabetic A1c
reduces the risk of complications by 24% (Kirk et al., 2006; Wenzel & Unger, 2016).
Socioeconomic Status
Education
According to Tull and Roseman (2014), there is an inverse relationship between
education and income and the rate of diabetes between black and white adults. Yet with
higher levels of education and income, there is a decrease in the prevalence of chronic
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disease. In a study based off the National Health Interview Survey dated 1997-2002,
individuals with less than a high school education were 1.6 times more likely to develop
chronic disease compared to those with a 4-year college degree (Borrell, Dallo, & White,
2006; Sacerdote et al., 2012). This leads to the belief that higher educational levels
promote healthier behaviors and help to identify disease risk (Borrell et al, 2006;
Sacerdote et al, 2012). There are a limited number of studies that examine education
levels and prevalence of chronic disease, but no published studies that compare ethnicity
(Borrell et al, 2006). However, there are studies that have compared heart disease risk
factors to education and diabetes outcomes which show African Americans are at a
higher risk for heart disease than whites (Borell et al, 2006). This leads to the belief that
by improving educational outcomes, the risk of disease could be reduced (Sacerdote et
al., 2012). Leading to the purpose of comparing educational levels to disease burden
which is to show a relationship between levels of education and disease prevalence.
Income
HTN and diabetes have been established as important risk factors for the
development of heart disease. In most countries, the poorest people have the highest risk
of developing chronic disease and are the least able to afford medical care (Abegunde,
Mathers, Adam, Ortegon, & Strong, 2007). One view, on the development of disease,
focuses on the relationship between socioeconomic levels in lower-income populations
and the development of disease risk. According to Kim et al, the lower the income level,
the higher the burden of care becomes financially. Income levels are causes for poverty
and often chronic disease leads to poverty, lost productivity, and premature death
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(Geneau, et al., 2010). This research explored the relationship between heart disease
prevalence and income levels.
Access to Care
Access to care not only includes affordability, but transportation, the cost of
prescriptions, lab fees, and office visit charges (Kim, et al., 2016). Defined as a chronic
disease, diabetes and hypertension receive few financial resources geared towards
prevention (Geneau, et al., 2010). This research adds to the call for action established by
the World Health Assembly 2008-2013 Action Plan and the United Nations General
Assembly meeting in 2011 on chronic disease (Geneau, et al., 2010). With decreased
access to services those living in lower income areas are at an increased risk for
premature death and complications from chronic disease (Geneau, et al., 2010). Access to
care is explored in this research as a confounder to disease burden and focuses on access
to insurance.

Rationale for Study
There have been several studies that focus on HbA1c and cardiovascular disease.
As early as 1979, data from the Framingham Study was used to measure heart disease in
diabetics versus nondiabetics (Kannel & McGee, 1979). One of the primary studies on
heart disease and diabetes is the Action to Control Cardiovascular Risk in Diabetes
(ACCORD) trial. The purpose of that study was to prevent major heart disease in
individuals with T2DM. The secondary purpose of that study was to compare current
practice guidelines with more intensive glycemic control (NIDDK, n.d.). The main goal
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of the study was to measure major cardiovascular events at onset of diabetes. This
includes heart attack, stroke, or death from a cardiac event. The study, when complete,
aims to impact the treatment options and strategies of cardiovascular events in relation to
diabetic treatments (NIDDK, n.d.).
Other studies like the ACCORD study include the UKPDS and the Action in
Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled
Evaluation (ADVANCE) studies. The UKPDS study found a 21% reduction in
cardiovascular risk outcomes for every 1% reduction in HbA1c (Kirk et al., 2006). The
ACCORD study aimed to control hyperglycemia and hypertension. However, the design
of the ACCORD study and the results of the blood pressure target failed to identify an
optimal blood pressure range for diabetics. Studies that were conducted after the
ACCORD and ADVANCE trials are recommending a blood-pressure goal below 130/80
mm Hg in diabetic patients (Nilsson, 2010).
The DCCT trial was yet another clinical trial that was conducted from 1983 to
1993. This study showed that keeping blood glucose as close to normal as possible can
slow the progression of diseases related to diabetes (NIDDK, n.d.). After the DCCT trial,
a follow-up study was conducted called the Epidemiology of Diabetes Interventions and
Complications (EDIC) trial. This trial assesses the incidence and predictors of diabetic
complications and examines the impact intensive control has on the reduction of heart
disease risk (NIDDK, n.d.).
In research conducted by Cederberg et al. (2010), a study on Japanese showed
that HbA1c of 5.6-6.4% carried a hazard ratio of 13.7 for development of diabetes, this
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was the first research study conducted to show such a correlation. In addition, this
research also showed that the risk of heart disease is already increasing prior to high
glycemic levels in diabetics (Cederberg et al., 2010). This study concluded with the
finding that HbA1c and 2-hour glucose were associated with heart disease in women, but
not in men (Cederberg et al., 2010).
The Multi-Ethnic Study of Atherosclerosis (MESA) follows the Framingham
Heart Study of 1979, and other studies from the National Heart, Lung, and Blood
Institute by evaluating non-White race and ethnic groups (Bertoni, Kramer, Watson, &
Post, 2016; Burke, Lima, Wong, & Narula, 2016). The Framingham Heart Study
established diabetes as a cardiovascular risk factor (Bertoni et al., 2016). This association
led to diabetes being labeled as a precursor to coronary heart disease in 2002 showing
that diabetics have a two-fold risk of developing coronary heart disease with a Hazard
Ratio of 2.00 and a 95% confidence interval of 1.83 to 2.19 (Bertoni et al., 2016).
Despite the amount of research conducted on the correlation between diabetes and
heart disease, more research is needed to show the relation within ethnicities. The
ACCORD and ADVANCE trials focused on lowering glucose levels to prevent CVD risk
factors. The results were suggestive of improved outcomes for CVD when HbA1c was
well controlled. (Skyler et al., 2009) The UKPDS study showed a 15% reduction in heart
attacks, and a reduction in all-cause mortality after 10 years, with intensive glycemic
control (Skyler et al., 2009). These studies are suggestive that additional research is
needed to individualize models of care by population (Skyler et al., 2009). There is still
much left that is unknown about which diabetic population is greatest at risk despite
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numerous papers on diabetes and coronary heart disease (Bertoni et al., 2016). Leading to
the purpose of this research, to establish if HbA1c is a predictor of CVD in the diabetic
African American population by age group.

Summary and Conclusion
There is a lack of focused research to address HbA1c levels and CVD in African
American men. Several researchers agree that the need exists to identify gaps in care that
could prevent CVD from developing in those diagnosed with diabetes, while others agree
that the available data only focuses on white individuals (George et al., 2017). Access to
medical care also affects disease outcomes as does educational and income levels (Kim et
al., 2016). These variables are explored to identify additional risk factors related to
disease progression. This chapter concluded with the identification of the HBM as the
theoretical foundation for this research. This foundation was used to identify an
individual’s perceived seriousness of diabetic health threats, and help individuals become
more proactive in the disease process. In Chapter 3, I will address the research design, the
rationale for the research, and the review the research questions. The research
methodology and analysis plan are also explored in detail.
.
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Chapter 3: Methodology

Introduction
The purpose of this quantitative study was to assess for an association between
HbA1c and heart disease in known diabetic African American men. Chapter 3 includes a
discussion of the research design, the rationale for the research, and the research
questions. In this study, the independent variable was the HbA1c value, and the
dependent variable was heart disease. I employed a quantitative approach and used
multiple logistic regression. The population of this study was diabetic African-American
men. The sample size was calculated using a G*Power analysis. Data were retrieved from
the NHANES 2011–2016 survey and variables were pulled and cleaned prior to being
merged via the Statistical Package for Social Sciences (SPSS) data analysis software. In
this chapter, I also discuss validity as well as the ethical procedures of this study.

Research Design and Rationale
The research design for this project was quantitative, based on the format of the
NHANES data. For this study, the independent variable was the HbA1c value and the
dependent variable was heart disease gathered from NHANES data from 2011–2016,
with the goal being to analyze whether there is a relationship between the given variables
through statistical analysis (see Grand Canyon University, 2018). The modifier was age,
and the covariates were education, income, and access to care. I employed multiple
logistic regression using secondary data. A chi-square analysis was also conducted using
NHANES data.
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Research Questions and Hypotheses
The study addressed the following research questions:
Research Question 1: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old?
H01: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.
Ha1: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.
Research Question 2: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care?
H02: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care.
Ha2: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 after controlling for
education, income, and access to care.
Methodology
NHANES is an annual survey collected by the National Center for Health
Statistics under the CDC (CDC, 2017a). This data is collected to assess the health and
nutritional status of adults and children within the United States (CDC, 2017a). To ensure
the reliability of the data, those over the age of 60, African Americans, and Hispanics are
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oversampled (CDC, 2017a). Each participant is given a thorough examination by a
licensed physician and includes a dental exam, physical, and lab work (CDC, 2017a).
The interview is primarily completed in the home of individuals (CDC, 2017a). Other
locations include mobile health centers that travel to various locations within the country
(CDC, 2017a). Once all exams are completed, the information is entered into a computer
system where the NHANES data are later generated (CDC, 2017a). Since interviewers
use electronic devices, they no longer transcribe data, and the threat of incorrect
transcription has been eliminated (CDC, 2017a). All information is kept confidential and
privacy is protected by law (CDC, 2017a).
After approval from the Walden University IRB, I obtained, analyzed, and
cleaned the NHANES data to extract only the variables needed for this research. These
variables included gender, ethnicity, HbA1c values (i.e., glycohemoglobin), age,
education, income, and access to care. Heart disease encompassed CHD, HTN, high
cholesterol, heart attack, and stroke. Appendix A shows the variables where the data were
extracted.
Once the data were extracted and cleaned, I merged them by sequence number
into SPSS for analyses. A chi-square analysis was conducted to examine the association
between HbA1c and heart disease. In addition, a multiple logistic regression was
conducted to examine the association between HbA1c, heart disease, education, income,
and stroke.
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Population
In this study, I focused on African American men aged 30–64 years old who
participated in the 2011–2016 NHANES. Since African Americans are more likely to
develop T2DM than other racial/ethnic groups (Davis et al., 2015), they are at an
increased risk of developing heart disease. According to the CDC (2017a), across every
ethnicity, heart disease was either the primary or secondary cause of death in men. Heart
disease was also the primary cause of death in the African American population (24.1%),
with diabetes coming in as the sixth leading cause of death (4.6%; CDC, 2017b). Heart
disease was also the leading cause of death in Whites and American Indians (CDC,
2017b).
Sampling and Sampling Procedures
I drew the sample from the 2011–2016 NHANES data set and focused on diabetic
African American men aged 30–64 years old. Data were extracted based on age when
first told they had diabetes, ethnicity, education, family income, access to care, type of
heart disease, and HbA1c levels (see Appendix A). My inclusion criterion was AfricanAmerican men with diabetes between the ages of 30–64 years old. The exclusion criteria
included those men younger than 30 and over the age of 64, and those with no history of
diabetes or heart disease. I calculated the sample size via G*power 3.1 and found that a
minimum sample size of 208 was needed to achieve a power of 0.80 and an odds ratio of
1.5. This sample size was necessary to determine statistically significant differences.
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Archival Data
Participants included in NHANES are randomly selected based on a computer
algorithm (CDC, 2016). To begin the survey, all counties in the United States are divided
into 15 groups; each group has specific characteristics (CDC, 2016). One county from
each group is then selected, and those selected counties are then further divided into
smaller groups (CDC, 2016). All homes within these smaller groups are then interviewed
by trained NHANES interviewers (CDC, 2016).
To gain approval for use of the data set, I applied and obtained IRB approval from
Walden University. NHANES data are the most comprehensive public set of data
available. Other data are from private organizations and require secondary IRB approval,
making the NHANES data set the ideal choice since it encompasses public data.
Instrumentation and Operationalization of Constructs
NHANES is a national survey that was established in 1970 and was built from the
National Health Survey Act of 1956 (CDC, 2015a). The National Health Survey Act
created the foundation for the survey and established the sources for NHANES data
collection to include: individuals to be interviewed, clinical data and locations, and
medical care facilities (CDC, 2015a). These surveys were then carried out by the
National Center for Health Statistics (CDC, 2015a). From these studies, researchers saw
an emerging pattern that associated disease processes with dietary habits (CDC, 2015a).
This prompted the development of the NHANES survey, which has been collecting
annual data on nutrition and health statuses (CDC, 2015a). The survey has since
developed into the current annual survey, which randomly selects participants from
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across the United States (CDC, 2015a). All collected data are confidential and voluntary
(CDC, 2015a). Participants receive a free physical exam and personal interview (CDC,
2015a).
NHANES is an annual survey that collects data on chronic conditions and a
multitude of various ethnicities (CDC, 2015a). This collection of information was
appropriate for use in this study because the data are from a national survey that has
established validity and covers the main variables to be addressed. Since this is a
federally funded study, all laws about privacy and autonomy were followed. I cleaned the
data and narrowed the variables to the topic at hand.
Surveys are used to describe the characteristics of a population. In this study, the
NHANES survey was used to gather information on the health habits and health
outcomes of individuals. Surveys were developed to help establish trends and to describe
attitudes, behaviors, and characteristics of a population (Creswell, 2017). Surveys are
also designed to help identify the beliefs and attitudes of individuals (Creswell, 2017). In
this survey, health habits and the impact of those habits are being evaluated.
Reliability of the survey has been established through the repeated usage of the
survey over time. The results reported are duplicated and follow a systemic pattern. The
survey is modified and adapted to the changing behaviors and medical conditions of
participants. Thus, validity is also established as the measurements are obtained,
analyzed, and published from the intended survey questions. Table 1 addresses the survey
questions that were extracted.
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Table 1
Exam Questions
Exam Question

Variable Code

Q1

Age when first told you have diabetes

DID040

Q2

Education level – Adults 20+

DMDEDUC2

Q3

Annual family income

INDFMIN2

Q4

Ever told you had high blood pressure

BPQ020

Q5

Doctor told you – high cholesterol level (HLD)

BPQ080

Q6

Glycohemoglobin

LBXGH

Q7

Ever told you had a heart attack

MCQ160E

Q8

Ever told you had a stroke

MCQ160F

Q9

Doctor told you, you have diabetes

DIQ010

Q10

Ever told you have coronary heart disease

MCQ160C

Q11

Gender

RIAGENDR

Q12

Race/Hispanic Origin

RIDRETH1

Operationalization of Variables
In this study, the independent variable was the HbA1c value, and the dependent
variable was heart disease. Abnormal HbA1c levels are defined as blood sugar greater
than 6.4% in diabetic patients as prediabetes is 5.7%–6.4% (ADA, 2018). HbA1c is
measured as a percent and assumes a role in the development of heart disease in African
American men (ADA, 2018). Heart disease was defined as having a history of CHD,
HTN, high cholesterol, heart attack, or stroke. Demographic variables included age,
education, income, and access to care.
I calculated variables using SPPS. The multiple logistic regression test was
conducted to establish a relationship between the given variables. HbA1c gives the
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diabetic values to compare to the presence of heart disease, and age allowed the variables
to be subdivided to compare categories based on the age of diabetes diagnosis and the
presence of heart disease.
Data Analysis Plan
NHANES data were accessed and variables pertinent to the study were extracted.
The objective was to assess for a correlation between HbA1c and heart disease while
controlling for age, education, income, and access to care among diabetic African
American men. Obtained data were cleaned to remove outliers and excess data not
relevant to the study. Data cleaning was conducted by year and by variables prior to the
data sets being merged into one SPSS data file. NHANES weights data to account for the
survey design used during data collection. Each individual surveyed is weighted to
account for the total number of individuals represented in the survey. When performing
the data analysis weighting does not need to be readdressed.
This study is limited to African American males diagnosed with diabetes aged
30–64 years old. Age 30 was chosen to minimize the chance of including only Type 1 or
juvenile diabetics, and age 64 was chosen since there is a greater chance of preexisting
cardiovascular complications by this age. Once data were obtained and merged, only
diabetic males between 30-64 remained. All other data and missing values were omitted.
In addition, participants were categorized by age groups and each participant was coded
by HbA1c levels (Appendix B). All assumptions for multiple logistic regression were
tested. Data analysis was completed using SPSS Version 21. The dependent variable was
labeled and measured on a binary scale, and the independent variables were nominal
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(Lund Research, 2018). The Durbin-Watson was conducted to check for independence of
observations, and a linear relationship was tested using scatter plots (Lund Research,
2018). No outliers were identified. Scatter plots also showed the relationship between
variables (Lund Research, 2018).
For each age group, a bar chart was shown to represent the levels of HbA1c. In
addition, descriptive statistics were conducted on each variable. The presentation of the
findings is from simple to complex (univariate, bivariate, then multivariate). For each of
the variables, univariate frequencies and percentages are calculated for all categories of
each variable and displayed. For bivariate comparisons, each of the main variables
(HbA1c level, education level, income level, and access to care) was compared to
whether the person has heart disease (yes or no) using chi-square tests plus Phi’s statistics
to measure the strength of the relationship. For the multivariate analysis, a logistic
regression model was calculated using heart disease as the dependent variable, HbA1c as
the primary independent variable and education, income, and access to care as the control
variables.

Threats to Validity
External Validity
External validity can be threatened by misrepresentation. This misrepresentation
can come from individuals not understanding the questions, the conditions, or the
language in which the survey is being presented to them. Other threats to external validity
include the setting in which the survey is administered, treatment interference during the
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physical examination, low response rates, or high dropout rates. To ensure external
validity is not affected NHANES workers interview individuals in his/her home, go to the
individuals in mobile homes, and over-survey to ensure an adequate sample has been
obtained. Giving the number of years NHANES has collected data, the external validity
has been addressed. The same results are generalized and remain close to the same year
after year (Kalaian & Kasim, 2008).
Internal Validity
Internal validity starts with consistency. NHANES has been consistent with the
survey and redevelopment of survey’s since it first began in 1970. This type of validity is
shown when casual relationships can be made between variables (Lavrakas, 2011b). This
can be validated with NHANES by comparing results survey year to survey year. In this
current research, results should mirror the NHANES results while also making new
comparisons. Internal validity was established through history and maturation of the
questionnaires. Internal validity for this research was established via the instrumentation
of the survey tool and selection bias is avoided by the randomization of participants based
on geographical areas (see Lavrakas, 2011b).
Construct Validity
The secondary data comes from NHANES surveys which are data used for my
research. Construct validity cannot be established as NHANES data is nonsequential and
inferences cannot be made on how data are collected. However, threats may come from
the wording of the survey and the interpretation of each question (Lavrakas, 2011a).
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Trained personnel administer the survey to avoid creating construct validity (Lavrakas,
2011a).
Ethical Procedures
The purpose of this research was to assess for a correlation between HbA1c and
heart disease. After IRB approval, number 08-15-18-0392454, NHANES data were
accessed and cleaned to obtain the variables of interest for this study. Using SPSS and
logistic regression the correlation between the variables was evaluated. Participants were
obtained from secondary data thus there are no risks to participants as identification is
withheld and information is confidential.
Participants for this study were obtained via NHANES selection process and
participation was voluntary. Participants were given the right to withdraw and are aware
that the information provided is confidential and protected by federal privacy laws.
Individual participants are given a copy of all medical reports, and individuals were
helped to identify links between healthy behavior and chronic conditions. This
information is then made public, so interventions proposals and proactive care can be
established.
The data used for this research project is public data. The data collected was
assessed for how HbA1c factors lead to the development of heart disease in African
American men. The research was published in ProQuest and thus was available for public
viewing. There are currently no conflicts of interest, and funding is not needed at this
time.
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Summary and Conclusion
Using a quantitative research design and secondary data from NHANES, a data
set from 2011-2016 was analyzed. Variables that focused on HbA1c and heart disease
were extracted and then merged into one SPSS data file. In addition, a data set was
created to compare multiple types of heart disease in this population. Once imported a
chi-square analysis and a multiple logistic regression was conducted to assess for a
correlation between the dependent and independent variables. This information then
tested the hypothesis to prove if there is a correlation between HbA1c levels and the
development of heart disease. This chapter concluded with the chi-square analysis and
multiple logistic regression on the merged data. In Chapter 4, I will go into detail on the
data collection process, the coding of the variables in the analysis, and the analysis and
outcomes of each regression model.
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Chapter 4: Results

Introduction
The purpose of this quantitative study was to assess for an association between
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in
known diabetic African American men aged 30–64 years old. Covariates included
education, income, and access to care. In this chapter, I provide the results of the data
analysis to answer the research questions and to address the research hypotheses. A
description of the data sets used in the study and the descriptive analysis of the data is
provided. The inferential statistics used for answering the research questions are also
summarized.
Research Questions
I addressed the following research questions and corresponding hypotheses in this
study:
Research Question 1: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old?
H01: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.
Ha1: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old.

45
Research Question 2: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care?
H02: There is no association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care.
Ha2: There is an association between HbA1c levels and heart disease in
African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care.
Data Collection and Data Set Preparation
I merged NHANES data from 2011–2016 to establish an adequate number of
participants for analysis. These data were taken from an annual survey collected by the
National Center for Health Statistics, under the CDC, and included demographic
information such as age, gender, and ethnicity. Other questions included: five types of
heart disease (i.e., CHD, HTN, high cholesterol, heart attack, and stroke); education;
income; and access to care. Data from each year were cleaned and formatted to align with
the research questions. I combined data sets using the sequence numbers provided in each
data set. Missing data and data outside the scope of this study were excluded. The total
number of participants extracted from this data was N = 243.
Coding of Variables
Most variables were not recoded in this data set. I kept the variables in the
original format in which they were obtained from NHANES. The variable
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glycohemoglobin was recoded as: 1 for HbA1c less than 6.4 (well controlled), 2 for
HbA1c 6.5-7.9 (controlled), and 3 for HbA1c > 8 (not controlled; Mayo Clinic, 2019).
All variables can be found in Appendix B. For heart disease variables (i.e., high
cholesterol, high blood pressure, CHD, heart attack, and stroke) the number 1 was for yes
and 2 was for no. Table 2 shows the frequencies for the various types of heart disease.
Table 2
Heart Disease Frequencies
Yes

No

High cholesterol

155

88

High blood pressure

185

58

Coronary heart disease

21

222

Heart attack

22

221

Stroke

25

218

Descriptive Analysis
I generated descriptive statistics based on the number of African American
diabetic males and their education level, income level, and access to care. Clinical
characteristics included the type of heart disease, the age of diagnosis, and HbA1c values.
Education level was categorized into high school graduate, some college or Associates of
Arts training, and college graduate or above (see Table 3). Annual family income is
shown in Table 4, and the type of access to care is shown in Table 5, with 91.8% of
participants having some form of health insurance. Table 4 further indicates multiple
types of insurance, and an N value greater than 243 is due to an individual having
multiple types of insurance.
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Table 3
Education Level

Education
level

f

%

High school graduate or less

133

54.7%

Some college or AA

65

26.7%

College graduate or above

45

18.5%

Note. High school graduate includes those with GED or no diploma. N = 243.

Table 4
Annual Family Income
Annual income

Missing

f

%

0-$9,999

20

8.2

$10,000 - $19,999

43

17.6

$20,000 - $44,999

71

29.1

$45,000 – $74,999

50

20.6

$75,000-$99,999

19

7.8

$100,000 and over

31

12.8

9

3.9

Note. Data were categorized from original NHANES data.
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Table 5
Access to Care
f

%

Covered by health insurance

223

91.8

Not covered by insurance

20

8.2

Private insurance

118

48.6

Single service plan

4

1.6

Medicare

101

41.6

Military health care

25

10.3

Other government insurance

14

5.8

Medicaid

30

12.3

State sponsored health plan

10

4.1

Types of insurance
Covered by private insurance

Covered by government
insurance

Covered by state insurance

Types of heart disease are classified in Table 6. Those with high blood pressure
accounted for 76.1% of total participants, while those with high cholesterol totaled 63.8%
of participants. In addition, those with high cholesterol and high blood pressure
accounted for 39.1% of total participants. A large proportion of participants were
diagnosed with diabetes between the ages of 40–49 years of age (see Table 7), and those
participants had an HbA1c ranging from 6.4–7.9 (see Table 8).
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Table 6
Type of Heart Disease
f

%

155

63.8

High blood pressure

185

76.1

Coronary heart disease

21

8.6

Heart attack

22

9.1

Stroke

25

10.3

High cholesterol & high blood pressure

95

39.1

High cholesterol, high blood pressure, & stroke

8

3.3

High cholesterol, high blood pressure, & heart attack

6

2.5

High cholesterol, high blood pressure, & coronary heart disease

6

2.5

High blood pressure & stroke

5

2.1

High cholesterol, high blood pressure, coronary heart disease, & heart attack

4

1.6

High blood pressure & heart attack

3

1.2

High cholesterol, high blood pressure, heart attack, & stroke

3

1.2

High cholesterol, high blood pressure, coronary artery disease, & stroke

2

.8

High blood pressure & coronary heart disease

2

.8

Other forms of mixed heart disease

8

3.2

No form of heart disease

24

9.9

Single heart disease

High cholesterol

Multiple heart diseases

Note. Individual percent is based off total N = 243.

50
Table 7
Age When Participant First Told They had Diabetes

Age in years

Age in years

f

%

30-39

36

14.8

40-49

78

32

50-59

74

30.6

60-64

30

12.3

Over 65

5

2.1

20

8.2

Missing
Note. Data were categorized from original data.

Table 8
HbA1c Level

Glycohemoglobin Level (HbA1c)

HbA1c range

f

%

4.5 – 6.4

73

30.0%

6.5 – 7.9

98

40.3%

8 – 16.5

72

29.6%

Note. Data were categorized from original data.

Description of the Study Sample
The study population was representative of 243 adult, African American, diabetic
males. The sample was drawn from NHANES 2011–2016 data. The average participant
(54.7%) had a high school education or less, earned $20,000–$44,999 (29.1%), and had
insurance (91.8%). Of those that had insurance, 57.7% had government insurance either
through Medicare, military health care, or other forms of government insurance. The
remaining participants had some college or an associate degree (26.7%) or were
considered a college graduate (18.5%). The distribution of HbA1c values ranged from
4.5–16.5. This distribution is shown below in Figure 1.
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Figure 1. Distrubution of HbA1c values.
Figure 1 shows the distribution of HbA1c to be skewed to the left. While the
average HbA1c was 7.6%, the lowest reported value was 4.5% and the highest reported
value was 16.5%. Of that population, 73 had an HbA1c of less than 6.4 (i.e., well
controlled), 98 had an HbA1c from 6.5%–7.9% (i.e., controlled), and 72 had an HbA1c
of > 8% (i.e., not controlled). The histogram of age at the time of diagnosis is slightly
skewed right with the average age of diagnosis being 50.5. This is shown in Figure 2.
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Figure 2. Age of diabetes diagnosis.
Chi-Square Analysis – Research Question 1
With Research Question 1, I asked: Is there an association between HbA1c levels
and heart disease in African American men with diabetes aged 30–64 years old? Chisquare analysis was run to compare the association between heart disease and HbA1c
values. No association was found between heart disease and HbA1c values; therefore, I
failed to reject the null hypothesis. There is no association between HbA1c levels and
heart disease in African American men with diabetes aged 30–64 years old.
To determine this, I conducted a chi-square test for association between high
blood pressure and HbA1c. Statistical assumptions were tested and met. In addition, all
expected frequencies were greater than five. There was no statistically significant
association found between high blood pressure and HbA1c x2(2) = 1.085, p = .581. Chisquare was then conducted on high cholesterol levels and HbA1c. All expected
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frequencies were greater than five and there was no statistical significance found x2(2) =
1.763, p = .414. The chi-square between CHD and HbA1c was conducted with all
frequencies being greater than five. No statistical significance was found x2(2) = 2.799, p
= .247. I also conducted chi-square analysis on heart attack and HbA1c and found all
expected frequencies were greater than five and no statistical significance x2(2) = .526, p
= .769. Chi-square analysis was conducted on stroke and HbA1c. All expected
frequencies were greater than five, and no statistical significance was found between
stroke and HbA1c x2(2) = .484, p = .785. Lastly, I conducted chi-square analysis on high
cholesterol and high blood pressure and found all expected frequencies were greater than
five and no statistical significance x2(2) = .850, p = .654. Table 9 shows the outcome for
the chi-square analyses.
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Table 9
Chi-Square Analysis
Pearson’s Chi-square

Chi-square

df

p value

Phi

Ever told you have high blood pressure

1.085

2

.581

.067

Doctor told you high cholesterol

1.763

2

.414

.085

Ever told you had coronary heart disease

.2799

2

.247

.107

Ever told you had heart attack

.526

2

.769

.047

Ever told you had a stroke

.484

2

.785

.045

High cholesterol & high blood pressure

.850

2

.654

.059

Note. Association between HbA1c and heart disease.

Multiple Logistic Regression – Research Question #2
With Research Question 2, I asked: Is there an association between HbA1c levels
and heart disease in African American men with diabetes aged 30-64, after controlling for
education, income and access to care? Multiple logistic regression was conducted to
compare the association between heart disease, HbA1c, education, income, and access to
care among diabetic African American men age 30-64.
Multiple logistic regression was performed to determine the effects of education,
income, and access to care on the likelihood that HbA1c levels would contribute to high
blood pressure in the male African American population aged 30-64. Assumptions were
tested and there is a linear relationship between the continuous independent variable and
transformation of the dependent variable, the data does not have multicollinearity, and
there were no significant outliers.
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The logistic regression model was not statistically significant, x2(4) = 3.363,
p=.515. The model explained 2.1% (Nagelkerke R2) of the variance in high blood
pressure and correctly classified 76.1% of the cases. Of the predictor variables, none were
statistically significant as seen in Table 10. Therefore, we reject the alternative hypothesis
and accept the null hypothesis. There is no association between HbA1c levels and heart
disease (high blood pressure) in African American men with diabetes aged 30-64, after
controlling for education, income and access to care.
Table 10
High Blood Pressure, Education, Income, Access to Care, and HbA1c
95% C.I.for
EXP(B)
B

S.E.

Wald

df

Sig.

Exp(B) Lower

Upper

.108

.134

.650

1

.420

1.114

.857

1.447

Annual family
income

-.070

.040

3.114

1

.078

.932

.862

1.008

Covered by health
insurance

.040

.548

.005

1

.942

1.041

.356

3.045

Glycohemoglobin

.028

.196

.020

1

.887

1.028

.700

1.510

Constant

-1.085

.873

1.543

1

.214

.338

Step 1a Education level Adults 20+

*Note. Logistic Regression Predicting Likelihood of High Blood Pressure based on Education, Income,
Access to Care, and Glycohemoglobin. a. Variable(s) entered on step 1: Education level - Adults 20+,
Annual family income, Covered by health insurance, Glycohemoglobin.

Multiple logistic regression was performed to determine the effects of education,
income, and access to care on the likelihood that HbA1c levels would contribute to high
cholesterol in the male African American population aged 30-64. The logistic regression
model was not statistically significant, x2(4) = 1.961, p=.743. The model explained 1.1%
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(Nagelkerke R2) of the variance in high cholesterol and correctly classified 63.8% of the
cases. Of the predictor variables, none were statistically significant as seen in Table 11.
There is no association between HbA1c levels and heart disease (high cholesterol) in
African American men with diabetes aged 30-64, after controlling for education, income
and access to care.
Table 11
High Cholesterol, Education, Income, Access to Care, and HbA1c
95% C.I.for
EXP(B)
Step
1a

Education level Adults 20+
Annual family
income
Covered by health
insurance
Glycohemoglobin
Constant

B
-.003

S.E.
.117

Wald
.001

-.011

.034

.101

1

.751

.989

.926

1.057

.131

.482

.074

1

.786

1.140

.443

2.929

-.224

.174

1.655

1

.198

.799

.568

1.125

-.170

.769

.049

1

.825

.844

df
1

Sig. Exp(B) Lower Upper
.976
.997
.793 1.252

*Note. Logistic Regression Predicting Likelihood of High Cholesterol based on Education, Income, Access
to Care, and Glycohemoglobin. a Variable(s) entered on step 1: Education level - Adults 20+, Annual
family income, Covered by health insurance, Glycohemoglobin.

Multiple logistic regression was performed to determine the effects of education,
income, and access to care on the likelihood that HbA1c levels would contribute to
coronary heart disease in the male African American population aged 30-64. The logistic
regression model was not statistically significant, x2(4) = 1.460, p= .834. The model
explained 1.3% (Nagelkerke R2) of the variance in coronary heart disease and correctly
classified 91.4% of the cases. Of the predictor variables, none were statistically
significant as seen in Table 12. Therefore, we fail to reject the null hypothesis. There is
no association between HbA1c levels and heart disease (coronary heart disease) in
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African American men with diabetes aged 30-64, after controlling for education, income
and access to care.
Table 12
Coronary Heart Disease, Education, Income, Access to Care, and HbA1c
95% C.I.for
EXP(B)
Step
1a

Education level Adults 20+
Annual family
income
Covered by health
insurance
Glycohemoglobin
Constant

B
.050

S.E.
.201

Wald
.062

.045

.061

.547

1

.459

1.046

.928

.664

1.056

.396

1

.529

1.943

.245 15.389

-.092

.296

.096

1

.757

.912

1.343

1.457

.850

1

.357

3.830

df
1

Sig. Exp(B) Lower Upper
.803 1.051
.709 1.558

.511

1.179

1.630

*Note. Logistic Regression Predicting Likelihood of Coronary Heart Disease based on Education, Income,
Access to Care, and Glycohemoglobin. a. Variable(s) entered on step 1: Education level - Adults 20+,
Annual family income, Covered by health insurance, Glycohemoglobin.

Multiple logistic regression was performed to determine the effects of education,
income, and access to care on the likelihood that HbA1c levels would contribute to a
heart attack in the male African American population aged 30-64. The logistic regression
model was not statistically significant, x2(4) = 6.326, p=.176. The model explained 5.6%
(Nagelkerke R2) of the variance in heart attack and correctly classified 90.9% of the
cases. Of the predictor variables, none were statistically significant as seen in Table 13.
Therefore, we accept the null hypothesis. There is no association between HbA1c levels
and heart disease (heart attack) in African American men with diabetes aged 30-64, after
controlling for education, income and access to care.
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Table 13
Heart Attack, Education, Income, Access to Care, and HbA1c
95% C.I.for
EXP(B)
Step
1a

Education level Adults 20+
Annual family
income
Covered by health
insurance
Glycohemoglobin
Constant

B
.352

S.E.
.198

Wald
3.147

.038

.062

.375

1

.540

1.039

.920

.804

1.061

.575

1

.448

2.235

.280 17.871

-.167

.292

.327

1

.567

.846

.465

1.420

.107

1

.744

1.592

df
1

Sig. Exp(B) Lower Upper
.076 1.422
.964 2.098

.477

1.173

1.500

*Note. Logistic Regression Predicting Likelihood of Heart Attack based on Education, Income, Access to
Care, and Glycohemoglobin. a Variable(s) entered on step 1: Education level - Adults 20+, Annual family
income, Covered by health insurance, Glycohemoglobin.
Multiple logistic regression was performed to determine the effects of education,
income, and access to care on the likelihood that HbA1c levels would contribute to stroke
in the male African American population aged 30-64. The logistic regression model was
statistically significant, x2(4) = 10.186, p=.037. The model explained 8.5% (Nagelkerke
R2) of the variance in stroke and correctly classified 89.7% of the cases. Of the predictor
variables income was statistically significant (p=.036). However, the glycohemoglobin
level is no significant (p=.567). Increased income was not associated with an increased
likelihood of stroke as seen in Table 14. Therefore, we fail to reject the null hypothesis.
There is no association between HbA1c levels and heart disease (stroke) in African
American men with diabetes aged 30-64, after controlling for income.
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Table 14
Stroke, Education, Income, Access to Care, HbA1c
95% C.I.for
EXP(B)

Step
1a

B
.222

S.E.
.185

Wald
1.442

Annual family
income

.135

.064

4.394

1

.036

1.145

1.009

1.299

Covered by health
insurance

.176

.791

.050

1

.823

1.193

.253

5.620

Glycohemoglobin

.130

.276

.223

1

.637

1.139

.663

1.957

Constant

.151

1.189

.016

1

.899

1.163

Education level Adults 20+

df
1

Sig. Exp(B) Lower Upper
.230 1.249
.869 1.796

*Note. Logistic Regression Predicting Likelihood of Stroke based on Education, Income, Access to Care,
and Glycohemoglobin a. Variable(s) entered on step 1: Education level - Adults 20+, Annual family
income, Covered by health insurance, Glycohemoglobin.

Summary and Conclusion
This chapter concluded with the results of the data analysis for heart disease and
HbA1c in African American men age 30-64. This study was conducted with NHANES
data from 2011-2016, and missing data were excluded from this study. For Research
Question #1 a chi-square analysis was conducted. All assumptions were tested and met.
This concluded that there is no statically significant association between heart disease and
HbA1c in this population. Multiple logistic regression was conducted for Research
Question #2. This tested for an association between heart disease, HbA1c, education,
income, and access to care. The analysis concluded that there is no association between
HbA1c levels, education, income, and access to care. The strengths and limitations of this
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study were discussed and recommendations for future research were explored. Chapter 5
will give an interpretation of the study results presented in this chapter based on the
theory of this study. Chapter 5 will also explore social change and give a final overview
of the research study.
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Chapter 5: Discussions, Conclusions, and Recommendations

Introduction
The purpose of this quantitative study was to assess for an association between
HbA1c (i.e., the independent variable) and heart disease (i.e., the dependent variable) in
known diabetic, African American men aged 30–64 years old. The covariates were
education, income, and access to care. In this chapter, I discuss the results, study
limitations, and implications for social change. In addition, recommendations for future
research and concluding ideas about the findings of the study are provided. Whiteley et
al. (2005) suggested that diabetes risk factors be treated as aggressively as heart disease
risk factors. While there is some ethnicity-based research on the relationship between
diabetes and heart disease in the field, there are limited published data by ethnicity.
African Americans are 2 times more likely to be diagnosed with diabetes than
non-Hispanic Whites (DHHS, 2016). Further research in 2010 corroborated these
findings and added that in the ADA’s view, evidence exists to support an association with
higher HbA1c levels and heart disease (Matsushita et al., 2010; Selvin et al., 2010). I
aimed to add to the knowledge in the field by analyzing secondary NHANES data from
2011–2016. I developed the following research questions to guide this study:

Research Question 1: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old?
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Research Question 2: Is there an association between HbA1c levels and heart
disease in African American men with diabetes aged 30–64 years old after
controlling for education, income, and access to care?
I conducted the study using chi-square analysis and multiple logistic regression.
Findings from this study showed that there is no significant relationship between any of
the covariates tested. However, the significance of income and high blood pressure (p =
.078), education and heart attack (p = .076), or income and stroke (p = .036) are
questioned given the small sample size of these populations (see Table 15). Overall, there
were no significant findings between heart disease and HbA1c values in this population.
Table 15
Summary of Findings

95% C.I.for EXP(B)
B
.352

S.E.
.198

Wald
3.147

Annual family
income

-.070

.040

3.114

1

.078

.932

.862

1.008

Annual family
income

.135

.064

4.394

1

.036

1.145

1.009

1.299

Heart
attack

Education level adults 20+

High
blood
pressure
Stroke

df
1

Sig. Exp(B) Lower
.076 1.422
.964

Upper
2.098

Note. HbA1c, heart disease, education, and income levels.

Interpretation of the Findings
The AHA and the ADA agree that lifestyle and medical interventions can delay
or reduce the development of heart disease (Buse et al., 2007). According to Babikr et al.
(2016), studies in adults have shown that early diabetic interventions reduce
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cardiovascular complications and mortality. Yet, African Americans are not receiving
recommended treatments (Vulic et al., 2010).
I conducted a chi-square analysis to test Research Question1. The chi-square
analysis showed no association between heart disease and HbA1c levels. For Research
Question 2, the multiple logistic regression showed no association between heart disease,
HbA1c levels, education, income, and access to care.
One possible reason for the lack of significance in heart disease and HbA1c is due
to the sample size of the population that reported having heart disease. While the total
number of participants was enough for this study, each type of heart disease needs to
encompass a larger sample size. The total N value for each type of participant is seen in
Table 6. With more participants, the outcome of the analysis could change.
Another possible reason for this outcome is the natural progression of the disease.
Diabetes often leads to vascular complications, which manifest in the kidneys first
(Mouton et al., 2017). This damage to the kidneys then causes high blood pressure and
subsequent heart disease (NIDDK, 2017). My findings in the literature review confirmed
that kidney disease is an issue in African Americans. Diabetic African Americans have a
46% higher chance of developing kidney disease and kidney failure resulting in dialysis
than non-Hispanic Whites (Kirk et al., 2006). African Americans also have a higher
prevalence of chronic conditions to include heart disease and stroke (Thorpe Jr. et al.,
2017).
The HBM, used as the theoretical framework in this study, allows for intervention
measures and education to be provided to this population. In addition, the belief of how
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the disease progresses and is treated can be incorporated into lifestyle changes based on
the risk factors identified in the results. My recommendation is for further research on the
association between kidney disease and heart disease or kidney disease and HbA1c levels
in this diabetic population.
Limitations of the Study
The limitations of this study came from the use of secondary data. Bias can come
from several sources and include the researcher, lack of authenticity, and outdated study
methods (Revise Sociology, 2017). The main limitation was missing data from the
dependent variables. No explanation was given as to why data were missing, but it can be
assumed that a participant left the question blank during the survey.
Other limitations came from the data sets. Individual data sets did not allow for an
adequate number of participants. This required the merging of additional data sets until
an adequate sample size could be obtained. I added the most recent year (2015–2016) and
the previous year’s data (2011–2012) to the data set being analyzed. Each data set was
cleaned and included male, diabetic individuals over the age of 29 and under the age of
65. This significantly reduced the number of eligible participants. Again, the lack of an
adequate sample size for each individual type of heart disease may have affected the
results of this study.
As stated in Chapter 1, another study limitation came from the inability to identify
the type of diabetes a participant has. To eliminate Type 1 diabetics, participants were
limited to those over 30 years of age. However, this created the potential to miss Type 2
diabetics under 30, which includes both adults and children.
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In addition, limitations were put on how HbA1c data was obtained. I conducted
the initial analysis using self-reported HbA1c levels, which significantly reduced the
available number of participants, thus the HbA1c level was replaced with a collected lab
value (i.e., glycohemoglobin) to increase the number of participants in the analysis.
Additionally, to analyze the various types of heart disease, I created a data set to merge
heart disease types. This allowed for individuals with multiple forms of heart disease to
be identified and analyzed.
Recommendations
African Americans have similar rates of high cholesterol as Whites, and they also
tend to have high blood pressure related to renal disease (DHHS, 2016). According to the
DHHS, Office of Minority Health, this population is twice as likely to develop diabetes
and suffer from end-stage renal disease (DHHS, 2016). In 2008, 461.7 per 100,000
individuals were diagnosed with end-stage renal disease (CDC, 2016).
I conducted this study using NHANES data from 2011–2016 to examine the
association between HbA1c and heart disease in African American men aged 30–64 years
old. In addition, the association between HbA1c, heart disease, education, income and
access to care was also evaluated using multiple logistic regression. There are a limited
number of extant research studies that focused on ethnicity in relation to diabetes and
heart disease (Raj, Bhatti, Badada, & Ramteke, 2015). I would recommend that this study
be expanded to include the association between kidney disease, HbA1c, heart disease,
and multiple ethnicities and genders. I would also expand this study into other areas of
data collection, such as the NIDDK as well as organizations from the private and public
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sectors. While NHANES is all-encompassing, the data collected are randomized,
controlled data that are geographical, thus expanding into other areas may provide
different results.
Additionally, future research could explore the effectiveness of diabetic
prevention programs for those at higher risk of heart disease based on HbA1c values. The
ADA agrees that lifestyle and medical interventions can delay or reduce the development
of heart disease, allowing diabetics to live longer, healthier lives (Buse et al., 2007).
While access to care did not prove to be a confounder, patient outcomes are affected by
income levels. Therefore, programs should focus on the needs of each individual
population and not just the entire population as one.
Implications
According to Walden University (2017), social change is working to better foster
social change “through research, projects, community engagement, and the education of
scholar-practitioners” (Walden University, 2018, para 3). The social change implications
of this study are influenced by socioeconomic factors, such as income and education, and
are predictors of high blood pressure, heart attack, and stroke in diabetic African
American men. Therefore, diabetic control and prevention programs need to account for
these factors.
While social change is designed to help individuals within a community, having
the necessary resources to assist this population must first be identified and established.
Understanding the characteristics of a diabetes diagnosis is essential to establishing
therapeutic goals to prevent CVD. As part of Walden Universities 2020 plan for social
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change, this can help to create “a positive impact on society and create benefits for the
public” (Walden University, 2017, p.7). This is established by educating individuals on
diabetic outcomes and the prevention of diabetic complications such as heart disease.
When individuals are given the information needed to make informed health care
decisions, ownership is established. With ownership comes control of the disease and
improved lifestyle and disease management.
In part of the literature review, I focused on an algorithm for disease management.
This information can be added to that literature as part of the education needed to make
an informed decision on the lifestyle an individual chooses to maintain control of the
disease process. While the results of this study did not clearly prove the correlation
between heart disease and HbA1c levels, the literature shows that more research is
needed. This additional research could help to identify potential disparities in HbA1c
values and the development of heart disease (Jeppesen et al., 1998; Traylor et al., 2010).
In addition, this research will help individuals to understand the relationship between
high blood sugars (i.e., HbA1c) and heart disease (George et al., 2017).
Conclusion
To manage disease, a person must be aware of the consequences of not managing
the disease. When speaking about diabetes this can include heart disease, renal disease,
blindness, and even death (CDC, 2016). I conducted this study to show the association
between HbA1c and heart disease, and while the results failed to show that association,
one may exist in other ethnicities and genders. There is ample data to support an
association between heart disease and HbA1c in White individuals, but there remains a
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lack of research on this topic in other ethnicities. With this study, I addressed the gap in
the literature that exists for this population but no other ethnicities.
While the findings of this study failed to demonstrate an association between
HbA1c and heart disease, using a larger population may change that outcome. In
addition, though no statistical significance was found between education and heart attack
or income and high blood pressure, the risk is still present, and the results should not be
discounted. The use of HBM ties in education to prevention, and with better education,
diabetic outcomes can be improved.
Proper management of diabetes can lead to an improvement in the overall health
and well-being of diabetic individuals. However, future research is needed to establish
whether renal disease is a factor to consider in the development of heart disease of
diabetic African American males. Research has shown that heart disease is most
prevalent in the African American community, and African Americans are more likely to
have diabetes than Whites (DHHS, 2016). They are also 4.2 times more likely to develop
renal disease from diabetes (DHHS, 2016). Therefore, a larger sample should be obtained
from other sources to better assess the outcome. A study should be conducted on HbA1c,
heart disease, and renal disease to establish whether adverse outcomes exist in this
population to provide stronger evidence to link HbA1c levels to heart disease in African
American men and create a proactive culture to treat those at the greatest risk from
developing secondary conditions related to diabetes.
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Appendix A: Table of the Variables Imported From Each File
Filename

Variables

Common Name

BPQ

BPQ020

Ever told you had high blood pressure

BPQ080

Doctor told you – High Cholesterol level

DIQ010

Doctor told you have diabetes

DID040

Age when first told you had diabetes

MCQ160C

Ever told you had coronary heart disease

MCQ160E

Ever told you had heart attack

MCQ160F

Ever told you had a Stroke

RIAGENDR

Gender

RIDAGE YR

Age in years at screening

RIDRETH1

Race/Hispanic origin

DIQ_H

MCQ_H

DEMO

DMDEDUC2 Education level – Adults 20+

HIQ_H

GHB_H

INDFMIN2

Annual family Income

HIQ011

Covered by health insurance

HIQ031A

Covered by Private Insurance

HIQ031B

Covered by Medicare

HIQ031D

Covered by Medicaid

HIQ031H

Covered by state-sponsored health plan

HIQ031I

Covered by other Government Insurance

HIQO31J

Covered by single service plan

HIQO31AA

No Coverage of any type

HIQ031F

Covered by military health care

LBXGH

Glycohemoglobin (%)
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Appendix B: Coding of Variables
Variable

Common Name

Original Categories

New Categories

DID040

Age when first
told you had
diabetes

Age in number

LBXGH

Glycohemoglobin Blood test A1C #
%

1. 0-29yrs
2. 30-39yrs
3. 40-49yrs
4. 50-59yrs
5. 60-64yrs
6. 65+yrs
1. Lowest – 6.3
2. 6.4-7
3. 7.1-8
4. 8.1-9
5. 9.1-10
6. 10.1-11
7. 11.1-12
8. 12.1-13
9. 13.1-14
10. Over 14.1
Recoded
1-1
2-1
3-1
4-2
5-2

DMDEDUC2 Education Level

INDFMIN2

Family Income

1. Less than 9th Grade
2. 9-11th Grade
(including 12th with
no diploma)
3. High School Graduate
or GED
4. Some College or AA
5. College Graduate or
Above
1. 0-4999
2. 5000-9999
3. 10000-14999
4. 15000-19999
5. 20000-24999
6. 25000-34999
7. 35000-44999
8. 45000-54999
9. 55000-64999
10. 65000-74999
11. (Missing)
12. 20000 and over
13. Under 20000
14. 75000-99999

Recoded
1-1
2-1
3-2
4-2
5-3
6-3
7-3
8-4
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15. 100000 and over

9-4
10-4
14-5
15-6
All other - 999

HIQ_

Access to Care

1. Covered by health
insurance
2. Covered by Private
Insurance
3. Covered by Medicare
4. Covered by Medicaid
5. Covered by statesponsored health plan
6. Covered by other
Government
Insurance GVTINS
15
7. Covered by single
service plan
8. No Coverage of any
type
9. Covered by military
health care

1. Private Insurance
(1/2/7)
2. Government
Insurance (3/6/9)
3. State Sponsored
(4/5)
4. No Coverage (8)

